Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock, par value $0.001 per share
2023-06-13$0.60/sh+3,102,878$1,861,727→ 4,917,749 total(indirect: Shares held through GD Holdings and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (2)
- [F1]Effective as of June 13, 2023, an aggregate amount of approximately $5,171,463 of principal and accrued interest in outstanding convertible debt held by GD Holdings converted in accordance with its terms into 3,102,878 shares of the Issuer's common stock.
- [F2]Includes 17,476 exchangeable shares of the Issuer's subsidiary.